Results 71 to 80 of about 122,296 (281)

Precision immunomodulation for pediatric hemophagocytic lymphohistiocytosis in intensive care

Pediatric Investigation, EarlyView.
This review presents a bedside framework for recognizing pediatric hemophagocytic lymphohistiocytosis and cytokine storm, stabilizing organ dysfunction, identifying the underlying phenotype, selecting targeted immunomodulation, considering extracorporeal adjuncts, and reassessing response within 24–72 h. ABSTRACT Hemophagocytic lymphohistiocytosis (HLH)
Weerapong Lilitwat, Prakreeti Bhandari
wiley   +1 more source

PSYCHIATRIC MORBIDITY IN PATIENTS UNDERGOING REHABILITATION AT ARMED FORCES INSTITUTE OF REHABILITATION MEDICINE

Pakistan Armed Forces Medical Journal, 2006
Background: Stress is a known predisposing factor for the development of herpes zoster. The purpose of this study was to describe the peculiar stressful circumstances of military service which may lead to physical ailments like herpes zoster.
Zulfiqar ur Rehman, Shahzad Rauf
doaj   +2 more sources

Sacral (S1) herpes zoster

, 2019
Anca Chiriac,1–3 Anca E Chiriac,4 Adrian Naznean,5 Cosmin Moldovan,6 Cristian Podoleanu,7 Simona Stolnicu81The Department of Dermato-Physiology, Apollonia University, Iaşi, Romania; 2Department of Dermatology, Nicolina Medical Center, Iaşi, Romania;
Chiriac A, Moldovan C, Naznean A, Podoleanu C, Stolnicu S, Chiriac AE   +5 more
core  

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5‐Year Analysis of the Phase 3 POETYK PSO‐1, PSO‐4, and Long‐Term Extension Trials

The Journal of Dermatology, EarlyView.
ABSTRACT Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, is approved in multiple countries for the treatment of moderate to severe plaque psoriasis, as well as generalized pustular and erythrodermic psoriasis in Japan. Deucravacitinib 6 mg once daily was efficacious and well tolerated through 3 years in the pooled population of ...
Yukari Okubo, Akimichi Morita, Yayoi Tada, Shinichi Imafuku, April W. Armstrong, Andrew Blauvelt, John Vaile, Zoran Popmihajlov, Janice Li, Rajesh Sawant, Katsuyoshi Habiro, Katsuki Tsuritani, Mamitaro Ohtsuki   +12 more
wiley   +1 more source

Canadian evidence‐based guidelines on spinal procedures for chronic pain

Anaesthesia, EarlyView.
Summary Introduction Interventional procedures are commonly used to diagnose and treat chronic pain of spinal origin but guidance on: their indications; frequency; technical conduct; requirements for image guidance; outcome measurement; and management of complications is lacking.
Anuj Bhatia, Philip Peng, Harsha Shanthanna, Yasmine Hoydonckx, James S. Khan, Elad Dana, Abeer Alomari, Tarvit Worravitudomsuk, Howard Meng, Martina Rekatsina, Ian Gilron, Andrea D. Furlan, Norman Buckley, Ian Beauprie, Roderick Finlayson, Paul Etheridge, Eldon Loh, Christopher Mares, Mohan Radhakrishna, Sebastian Mafeld, John X. Pereira, Hance Clarke, Shawn Marshall, Magali Robert, Pam Squire, Robert Tanguay, Danielle Alvares   +26 more
wiley   +1 more source

Systematic evaluation of the pharmacoeconomics research on herpes zoster vaccine administration: a systematic review

Zhongguo gonggong weisheng
ObjectiveTo systematically evaluate the pharmacoeconomic research on herpes zoster (HZ) vaccine administration, providing reference for related research and prevention of HZ.
Xinping LIU, Ziyi YANG, Xinyu LI, Yulan CHANG, Lei TIAN   +4 more
doaj   +1 more source

Herpes Zoster After Liver Transplantation: Incidence, Risk Factors, and Complications [PDF]

, 2004
Herpes zoster is the consequence of the reactivation of latent varicella-zoster infection. Immunosuppression may be a predisposing factor for herpes zoster.
Prieto, J. (Jesús), Pardo, F. (Fernando), Sangro, B. (Bruno), Álvarez-Cienfuegos, J. (Javier), Rotellar, F. (Fernando), Herrero, J.I. (José Ignacio), Quiroga, J. (Jorge)   +6 more
core   +1 more source

CAR‐HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B‐cell non‐Hodgkin lymphoma

British Journal of Haematology, EarlyView.
High versus low baseline CAR‐HEMATOTOX scores were associated with poorer safety and efficacy outcomes in patients with R/R B‐NHL who received odronextamab in the ELM‐1 and ELM‐2 studies. The CAR‐HEMATOTOX score may provide a readily available measure for identifying patients at risk of inferior clinical outcomes with odronextamab treatment.
Matthew Matasar, David Tucker, Tae Min Kim, Yuan Cheng, Jingjin Li, Saleem Shariff, Hesham Mohamed, Manjusha Namuduri, Aafia Chaudhry, Stefano Luminari   +9 more
wiley   +1 more source

Zoster Vaccines session : Introduction [PDF]

01-Zoster-Lee-508 ...

core   +2 more sources

Herpes zoster in Australia reply

, 2022
Herpes zoster in Australia ...
Hassan Vally (13074096), S J Conaty (13378263), A Jardine (7758998)   +2 more
core